Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page
Airlines to supermarkets: Living with Covid is tough in gridlocked economy

Airlines to supermarkets: Living with Covid is tough in gridlocked economy

by AIP Online Bureau | Jan 23, 2022 | Articles, Eco/Invest/Demography, Health, Pandemic

Still, as the pandemic persists into its third year, it’s becoming clearer by the day that a return to economic normality is some way off. The global economy is now split between those countries living with the virus and China’s dogged pursuit of Covid-zero From...

Pandemic darlings face the boot as investors eye return to normal life

by AIP Online Bureau | Jan 22, 2022 | Eco/Invest/Demography, Facts, Health, Pandemic, Technology

“What we think is very interesting is that Omicron, because of its very high infectiousness, very low morbidity compared to previous waves such as the Delta variant, might actually be the first tangible sign that the pandemic is evolving in the direction that we...

3 doses of mRNA Covid vaccines very effective against Omicron, Delta: Study

by AIP Online Bureau | Jan 22, 2022 | Facts, Health, Pandemic

“Our findings provide important evidence that booster shots are highly effective and those who are unvaccinated are at significantly greater risk of experiencing more severe Covid-19 outcomes and should get vaccinated and boostered as soon as possible,”...

India extends ban on international commercial flights till Feb 28

by AIP Online Bureau | Jan 19, 2022 | Health, Indian News, Pandemic

“This restriction shall not apply to international all-cargo operations and flights specifically approved by the DGCA. However, flights under Air Bubble agreement will not be affected,” stated the notification New Delhi: India’s civil aviation...

India’s Gennova developing Omicron-specific COVID-19 vaccine

by AIP Online Bureau | Jan 17, 2022 | Health, Indian News, Pandemic

The source said Gennova on Friday separately submitted to India’s drug regulator phase 2 trial data for its original mRNA vaccine candidate. The government said last year that product was found to be “safe, tolerable, and immunogenic” in the...
« Older Entries
Next Entries »

Recent Posts

  • Death toll from Texas floods reaches at least 43; dozens still missing
  • Gadkari’s mega mobility plan: Hyperloop, electric buses, ropeways on fast track
  • 425 under surveillance as Kerala battles fresh Nipah virus outbreak
  • Centre asks states to crack down on manufacturers selling sub-standard helmets
  • Sales of electric cars surge in June Shriram mobility report

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy